The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye

Bibliographic Details
Main Authors:	Stonecipher, Karl G, Torkildsen, Gail L, Ousler, George W, Morris, Scot, Villanueva, Linda, Hollander, David A
Format:	Online
Language:	English
Published:	Dove Medical Press 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874635/

Similar Items

Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study
by: Byun, Yong-Soo, et al.
Published: (2011)

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients
by: Stonecipher, Karl G, et al.
Published: (2013)

PERSIST: Physician’s Evaluation of Restasis® Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
by: Mah, Francis, et al.
Published: (2012)

An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye
by: Ousler, George, et al.
Published: (2015)

The Effect of Topical Cyclosporine 0.05% on Dry Eye after Cataract Surgery
by: Chung, Yeon Woong, et al.
Published: (2013)

The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
by: Turan-Vural, Ece, et al.
Published: (2011)

Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye
by: Meerovitch, Karen, et al.
Published: (2013)

Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial
by: Patane, Michael A, et al.
Published: (2011)

Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery
by: Lee, Jang Hoon, et al.
Published: (2016)

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis
by: Okumus, Seydi, et al.
Published: (2012)

Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
by: Bayraktutar, Betül N., et al.
Published: (2016)

Retrospective Review on the Use of Topical Cyclosporin A 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese
by: Wu, Macy M. S., et al.
Published: (2014)

Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion
by: Karn, Pankaj Ranjan, et al.
Published: (2014)

Automated grading system for evaluation of ocular redness associated with dry eye
by: Rodriguez, John D, et al.
Published: (2013)

Topical Ophthalmic Cyclosporine in the Treatment of Toxic Epidermal Necrolysis
by: Onaran, Zafer, et al.
Published: (2011)

Cyclosporine-Associated Leukoencephalopathy in a Case of Sympathetic Ophthalmitis
by: Tagami, Mizuki, et al.
Published: (2016)

Halometasone monohydrate (0.05%) in occupational contact dermatitis
by: Maiti, Rituparna, et al.
Published: (2016)

Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model
by: Liang, Hong, et al.
Published: (2012)

Formulation evaluation and validation of ophthalmic emulsion of docosahexaenoic acid
by: R. R. Nikhade, et al.
Published: (2014-03-01)

Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
by: Schultz, Clyde
Published: (2014)

Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
by: Clyde Schultz
Published: (2014-06-01)

Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
by: Clyde Schultz
Published: (2014-01-01)

Cyclosporine Amicellar delivery system for dry eyes
by: Kang, Han, et al.
Published: (2016)

Origin of colossal dielectric permittivity of rutile Ti0.9In0.05Nb0.05O2: single crystal and polycrystalline
by: Song, Yongli, et al.
Published: (2016)

Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
by: Sosne, Gabriel, et al.
Published: (2015)

Effects of sintering temperature on structure, magnetic and dielectric properties of La0.5Sr0.5Fe0.9Mn0.05Ti0.05O3 material
by: Handoko Erfan, et al.
Published: (2018-01-01)

On the challenges of drawing conclusions from p-values just below 0.05
by: Lakens, Daniël
Published: (2015)

Treatment of superficial basal cell carcinoma with ingenol mebutate gel, 0.05%
by: Bettencourt, Miriam S
Published: (2016)

Dry Eye: an Inflammatory Ocular Disease
by: Hessen, Michelle, et al.
Published: (2014)

Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections
by: Kanda, Yoshiko, et al.
Published: (2012)

SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model
by: Petrov, Anton, et al.
Published: (2016)

Effect of evolving microstructure on magnetic properties of nominal mg0.45zn0.5cu0.05 ferrite
by: Nur Asiha Binti Sazali
Published: (2015)

An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery
by: Yavuz, Burçin, et al.
Published: (2012)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
by: Inoue, Kenji, et al.
Published: (2012)

Emulsion of Chloramphenicol: an Overwhelming Approach for Ocular Delivery
by: Ashara Kalpesh C., et al.
Published: (2017-03-01)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
by: Nakakura, Shunsuke, et al.
Published: (2012)

Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye
by: Nguyen, Theresa, et al.
Published: (2011)

Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
by: Kashima, Tomoyuki, et al.
Published: (2014)

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
by: Koh, Shizuka
Published: (2015)

Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
by: Ueda, Kaori, et al.
Published: (2015)